Sichuan strives for common assisted reproduction to be included in medical insurance, and the medical insurance policy is expected to continue to expand

According to People.Cn Co.Ltd(603000) “leadership message board” on March 8, in response to the message of netizens suggesting “subsidizing assisted reproduction”, Sichuan Provincial Health Commission replied on March 8 that it plans to learn from the practices of individual provinces and cities and actively strive to include common assisted reproductive technology projects into the scope of medical insurance reimbursement in conjunction with relevant departments.

According to the calculation of Ping An Securities, the market space of assisted reproduction in China will exceed 68 billion in 2025, with a broad market space. Institutional analysis pointed out that in recent years, the policy guidance of the state to encourage childbirth has been obvious, and policies such as double single two child, single two child, comprehensive two child and three child childbirth policies have been launched successively, showing trends such as expanding regional coverage, more detailed landing policies and strengthening implementation, supporting the continued prosperity of the reproductive industry. The agency believes that the assisted reproductive health insurance policy is expected to be popularized throughout the country, superimposed with a series of measures to encourage fertility, which may further stimulate the release of demand and inject new growth impetus into industry development and related companies in the industrial chain.

According to the theme database of financial Associated Press, among the relevant listed companies:

Shenzhen Yhlo Biotech Co.Ltd(688575) has covered more than 20 projects in the field of reproductive health, including China’s first anti Mullerian hormone (AMH) chemiluminescence diagnostic reagent, inhibin B (inhb) chemiluminescence diagnostic reagent, toch and other advantageous diagnostic items. The detection items can run through pre pregnancy diagnosis, pregnancy diagnosis, postpartum diagnosis The whole reproductive health cycle from neonatal diagnosis to perimenopausal diagnosis.

Hybio Pharmaceutical Co.Ltd(300199) in terms of assisted reproduction, the varieties mainly include sitrik, atoxiban, cabe oxytocin and oxytocin. Each product covers multiple links of the assisted reproduction industry chain.

- Advertisment -